Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP739126.RAzr_ngXqYjaVECPw58Wq_axafu0JM8vAZJL_re8igFGM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP739126.RAzr_ngXqYjaVECPw58Wq_axafu0JM8vAZJL_re8igFGM130_assertion type Assertion NP739126.RAzr_ngXqYjaVECPw58Wq_axafu0JM8vAZJL_re8igFGM130_head.
- NP739126.RAzr_ngXqYjaVECPw58Wq_axafu0JM8vAZJL_re8igFGM130_assertion description "[The discovery of two major podocyte antigens, neutral endopeptidase (NEP), involved in rare cases of neonatal membranous nephropathy, and the M-type phospholipase A2 receptor 1 (PLA2R1), the first antigen discovered in adults, have been major 'breakthroughs' in our understanding of the pathogenesis of human membranous nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739126.RAzr_ngXqYjaVECPw58Wq_axafu0JM8vAZJL_re8igFGM130_provenance.
- NP739126.RAzr_ngXqYjaVECPw58Wq_axafu0JM8vAZJL_re8igFGM130_assertion evidence source_evidence_literature NP739126.RAzr_ngXqYjaVECPw58Wq_axafu0JM8vAZJL_re8igFGM130_provenance.
- NP739126.RAzr_ngXqYjaVECPw58Wq_axafu0JM8vAZJL_re8igFGM130_assertion SIO_000772 22240444 NP739126.RAzr_ngXqYjaVECPw58Wq_axafu0JM8vAZJL_re8igFGM130_provenance.
- NP739126.RAzr_ngXqYjaVECPw58Wq_axafu0JM8vAZJL_re8igFGM130_assertion wasDerivedFrom befree-20140225 NP739126.RAzr_ngXqYjaVECPw58Wq_axafu0JM8vAZJL_re8igFGM130_provenance.
- NP739126.RAzr_ngXqYjaVECPw58Wq_axafu0JM8vAZJL_re8igFGM130_assertion wasGeneratedBy ECO_0000203 NP739126.RAzr_ngXqYjaVECPw58Wq_axafu0JM8vAZJL_re8igFGM130_provenance.